Literature DB >> 12235059

Selected contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal alpha-tocopherol.

T Minko1, A Stefanov, V Pozharov.   

Abstract

The aim of this study is to examine the antioxidant and antiapoptotic activity of liposomal alpha-tocopherol (LAT) in anesthetized rats exposed to severe hypoxia. It was shown that intratracheal application of LAT normalized lung phospholipid composition and inhibited lipid peroxidation in lung tissues, which in turn decreased lung edema and damage and improved breathing pattern, oxygen diffusion, and lung gas exchange. LAT also limited the overexpression of genes encoding hypoxia inducible factor-1alpha and both studied forms of phospholipase A(2), and it increased the power of cellular antioxidant and antiapoptotic defense by overexpressing genes encoding Mn- and Cu-Zn-cofactored superoxide dismutases, Bcl-2, and heat shock 70 proteins. The overexpression of studied caspases and their activity were downregulated, which significantly (1.6-2 times) limited apoptosis in lung cells. Finally, all these positive changes decreased mortality during hypoxia from approximately 60% in untreated animals to approximately 30% in the group of rats treated with LAT. The data obtained indicate that LAT may be useful for the correction of hypoxic lung injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235059     DOI: 10.1152/japplphysiol.00007.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

1.  Lung oxidative stress as related to exercise and altitude. Lipid peroxidation evidence in exhaled breath condensate: a possible predictor of acute mountain sickness.

Authors:  O F Araneda; C García; N Lagos; G Quiroga; J Cajigal; M P Salazar; C Behn
Journal:  Eur J Appl Physiol       Date:  2005-09-30       Impact factor: 3.078

2.  Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.

Authors:  Refika I Pakunlu; Thomas J Cook; Tamara Minko
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

3.  Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

Authors:  S S Dharap; Y Wang; P Chandna; J J Khandare; B Qiu; S Gunaseelan; P J Sinko; S Stein; A Farmanfarmaian; T Minko
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-25       Impact factor: 11.205

4.  Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.

Authors:  Olga B Garbuzenko; Maha Saad; Seema Betigeri; Min Zhang; Alexandre A Vetcher; Viatcheslav A Soldatenkov; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

5.  Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

Authors:  Vera Ivanova; Olga B Garbuzenko; Kenneth R Reuhl; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Eur J Pharm Biopharm       Date:  2012-12-08       Impact factor: 5.571

6.  Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.

Authors:  G Mainelis; S Seshadri; O B Garbuzenko; T Han; Z Wang; T Minko
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-03-26       Impact factor: 2.849

7.  Combination antioxidant effect of α-tocoferol and erdosteine in ischemia-reperfusion injury in rat model.

Authors:  Talat Yurdakul; Haluk Kulaksizoglu; Mehmet Mesut Pişkin; Mustafa Cihat Avunduk; Esra Ertemli; Gürhan Gokçe; Hülagü Barişkaner; Sadik Byükbaş; Volkan Kocabas
Journal:  Int Urol Nephrol       Date:  2009-09-30       Impact factor: 2.370

8.  Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage.

Authors:  Seema Betigeri; Min Zhang; Olga Garbuzenko; Tamara Minko
Journal:  Drug Deliv Transl Res       Date:  2010-12-14       Impact factor: 4.617

9.  Liposomal Antioxidants for Protection against Oxidant-Induced Damage.

Authors:  Zacharias E Suntres
Journal:  J Toxicol       Date:  2011-08-16

Review 10.  Lung oxidative damage by hypoxia.

Authors:  O F Araneda; M Tuesta
Journal:  Oxid Med Cell Longev       Date:  2012-08-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.